Biotech | April 06, 2022
MilliporeSigma acquires MAST platform from Lonza
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
It also secures US $ 10 million for US launch and commercialization
It is an application to automate statistical analysis and reporting for clinical research.
Phablecare closed this acquisition for an undisclosed sum, betting on the start-up's holistic approach to Type 1 Diabetes management
The registry will be conducted for approximately two and a half years and up to 200 subjects will be enrolled
Vortioxetine is a novel antidepressant with multimodal activity, which is approved to treat Major Depressive Disorder (MDD) in adults
The science leader comes with a rich experience in the employment testing industry
Ozempic is now approved in the US at 0.5 mg,1.0 mg and 2.0 mg doses for the treatment of type 2 diabetes in adults
Launched in the year 2018, MedEngage Scholarship Program is aimed at nurturing and nourishing medical talent in India
Subscribe To Our Newsletter & Stay Updated
